REG - Transense Technlgy - Grant of Options

Transense TechnologiesAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260513:nRSM0399Ea&default-theme=true

RNS Number : 0399E  Transense Technologies PLC  13 May 2026

Transense Technologies plc

("Transense" or the "Company")

 

 Grant of share options

 

Transense Technologies plc (AIM: TRT), the provider of specialist sensor
technology and measurement systems, announces that on 12 May 2026, the
Company's remuneration committee (the "Remuneration Committee") approved the
grant of 100,000 share options (the "Options") to acquire ordinary shares
of 10 pence each in the Company ("Ordinary Shares") to Ryan Maughan, the
Company's Managing Director.

 

In accordance with the Company's share scheme, the Options are subject to
performance criteria and have an exercise price of 10 pence per share, being
nominal value, and can be exercised after three years until the tenth
anniversary of the grant. Two thirds of the Options are exercisable if the
Company's share price reaches or exceeds 150 pence per share for ten
consecutive trading days at any time, and no Options are exercisable unless
this is achieved. The remaining third are exercisable, in full, if the share
price reaches or exceeds 200 pence per share for ten consecutive trading
days at any time. None of this tranche is exercisable if the share price has
not reached 150 pence per share for ten consecutive trading days and a
pro‐rata amount will be exercisable between these two share price targets.

 

Following this grant, Ryan Maughan is now interested in a total of 450,000
share options in the Company.

 

205,000 additional Options have been granted to other employees on the same
basis. Following these grants, the Company has a total of 1,895,000 options
outstanding, representing approximately 11.53% of the Company's issued share
capital.

 

The Company's remuneration policy approved by shareholders by an advisory vote
at the Annual General Meeting in November 2024 permits overall headroom for
the grant of share options of 15% of the issued share capital in any ten year
period.

 

For further information please visit https://www.transense.com
(https://www.transense.com/)  or contact:

 

 Transense Technologies plc                                       Via Investor Relations

 Nigel Rogers (Executive Chairman)                                (see below)

 Ryan Maughan (Managing Director)

 Melvyn Segal (Chief Financial Officer)
 Cavendish Capital Market Limited (Nominated Adviser and Broker)  0207 220 0500

 Adrian Hadden / Callum Davidson (Corporate Finance)

 Jasper Berry (Sales)
 Investor Relations                                               Tel: +44 (0)1869 238380

 Anice McNamee                                                    Investor.relations@transense.co.uk

 

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on
AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company
develops and supplies advanced sensor technology and measurement solutions
used by some of the world's leading companies to improve performance,
efficiency, and safety in demanding, mission critical applications. Transense
currently operates through two active business segments:

SAWsense - designs, supplies and licences advanced sensor solutions based on
proven, patent protected Surface Acoustic Wave (SAW) technology to world
leading companies in aerospace, automotive, and industrial machinery
(including robotics), enabling improved efficiency and performance of their
products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied,
Airbus and several other confidential Tier One automotive, aerospace and
industrial machinery suppliers.

Translogik - develops smart, connected commercial vehicle tyre inspection
equipment to many of the world's leading tyre suppliers, fleet operators and
service centres. Enabling accurate measurement and digital capture of
safety-critical tyre condition data, used to reduce operating costs, improve
safety and provide audit records for regulatory compliance. Key customers
include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and
leading independent providers of vehicle fleet maintenance management
software, and a growing list of international territory distribution partners.

In addition, Transense earns residual royalty income from Bridgestone iTrack -
a tyre monitoring system for off-highway vehicles that was developed by
Translogik. The associated sales, support and development infrastructure were
sold to Bridgestone Corporation, the world's largest tyre producer, in June
2020, and the intellectual property was licensed exclusively to Bridgestone
under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/ (https://www.transense.com/)

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Ryan Maughan

 2    Reason for the notification

 a)   Position/status                                              Managing Director

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Transense Technologies plc

 b)   LEI                                                          2138005N52J6KKQ3EY67

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Options over Ordinary shares of 10 pence each

      Identification code                                          GB00BDHDTH21

 b)   Nature of the transaction                                    Grant of options

 c)   Price and volume                                             Exercise Price(s) 10p

                                                                   Volume(s) 100,000
 d)   Aggregated information

      - Aggregated volume                                          As above

      - Price

 e)   Date of the transaction                                      12 May 2026

 f)   Place of the transaction                                     Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFEEDIFLIR



            Copyright 2019 Regulatory News Service, all rights reserved